{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T00:43:31Z","timestamp":1740185011284,"version":"3.37.3"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T00:00:00Z","timestamp":1721088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T00:00:00Z","timestamp":1721088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100011852","name":"Paracelsus Medical University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100011852","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Urologie"],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title><jats:p>Bei steigender Lebenserwartung gibt es zunehmend \u00e4ltere (\u2265\u202f80\u00a0Jahre) PatientInnen mit der Diagnose eines muskelinvasiven Blasenkarzinoms. Therapie der Wahl ist die radikale Zystektomie mit Harnableitung (mit neoadjuvanter Chemotherapie, sofern belastbar). Die Auswahl der richtigen Harnableitung in Abw\u00e4gung von Morbidit\u00e4t gegen\u00fcber Funktionalit\u00e4t und Lebensqualit\u00e4t stellt eine Herausforderung dar. Das kalendarische Alter allein ist nicht entscheidend. Wegweisend ist v.\u202fa. eine ad\u00e4quate pr\u00e4operative Begutachtung mit Blick auf medizinische Besonderheiten sowie physische und kognitive Einschr\u00e4nkungen. Standardm\u00e4\u00dfig wird bei \u00e4lteren PatientInnen das Ileum-Conduit als inkontinente Harnableitung eingesetzt, da der Eingriff eine geringere Komplexit\u00e4t und Operationsdauer als eine kontinente Harnableitung aufweist. Fitte PatientInnen mit ad\u00e4quater Lebenserwartung und ausreichender Compliance k\u00f6nnen jedoch auch im hohen Alter Kandidaten f\u00fcr kontinente Harnableitungen sein. Die Ureterokutaneostomie mit Harnleiterschienendauerversorgung ist eine wichtige Alternative f\u00fcr multimorbide PatientInnen mit hohem perioperativem Risiko. Wichtig ist v.\u202fa. eine gute pr\u00e4operative Aufkl\u00e4rung, sodass PatientInnen eine informierte Entscheidung treffen k\u00f6nnen.<\/jats:p>","DOI":"10.1007\/s00120-024-02384-6","type":"journal-article","created":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T11:02:13Z","timestamp":1721127733000},"page":"795-803","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Harnableitung beim alten Patienten\u00a0(80+)","Urinary diversion in old patients\u00a0(80+ years)"],"prefix":"10.1007","volume":"63","author":[{"given":"D.","family":"Oswald","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. R. W.","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Netsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Hatiboglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Homberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. T.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Lehrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Miernik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Olbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. S.","family":"Sch\u00f6b","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. D.","family":"Sievert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. J.","family":"Gross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Pallauf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Deininger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Ramesmayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Lusuardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,7,16]]},"reference":[{"key":"2384_CR1","unstructured":"IARC (2024) Estimated number of new cases in 2022, worldwide, both sexes, all ages. 2020. Access Date March"},{"key":"2384_CR2","unstructured":"Robert Koch Insitut. Krebs in Deutschland 2019\/2020.; 2023."},{"issue":"5","key":"2384_CR3","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s00428-015-1739-2","volume":"466","author":"E Comp\u00e9rat","year":"2015","unstructured":"Comp\u00e9rat\u00a0E, Larr\u00e9\u00a0S, Roupret\u00a0M et\u00a0al (2015) Clinicopathological characteristics of urothelial bladder cancer in patients less than 40\u00a0years old. virchows Arch 466(5):589\u2013594. https:\/\/doi.org\/10.1007\/s00428-015-1739-2","journal-title":"virchows Arch"},{"issue":"1","key":"2384_CR4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/J.EURURO.2023.08.016","volume":"85","author":"AJ Witjes","year":"2024","unstructured":"Witjes\u00a0AJ, Bruins\u00a0MH, Carri\u00f3n\u00a0A et\u00a0al (2024) European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines. Eur Urol 85(1):17\u201331. https:\/\/doi.org\/10.1016\/J.EURURO.2023.08.016","journal-title":"Eur Urol"},{"key":"2384_CR5","doi-asserted-by":"publisher","unstructured":"Williams SB, Huo J, Chamie K, et\u00a0al. Underutilization of Radical Cystectomy Among Patients Diagnosed with Clinical Stage T2 Muscle-invasive Bladder Cancer. Eur Urol Focus. 2017;3(2\u20133):258\u2013264. https:\/\/doi.org\/10.1016\/J.EUF.2016.04.008","DOI":"10.1016\/J.EUF.2016.04.008"},{"issue":"3","key":"2384_CR6","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/J.1464-410X.2008.07636.X","volume":"102","author":"K Chamie","year":"2008","unstructured":"Chamie\u00a0K, Hu\u00a0B, DeVere White\u00a0RW, Ellison\u00a0LM (2008) Cystectomy in the elderly: does the survival benefit in younger patients translate to the octogenarians? bju Int 102(3):284\u2013290. https:\/\/doi.org\/10.1111\/J.1464-410X.2008.07636.X","journal-title":"bju Int"},{"issue":"1","key":"2384_CR7","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/J.UROLONC.2006.05.010","volume":"25","author":"EC Skinner","year":"2007","unstructured":"Skinner\u00a0EC, Stein\u00a0JP, Skinner\u00a0DG (2007) Surgical benchmarks for the treatment of invasive bladder cancer. Urol Oncol 25(1):66\u201371. https:\/\/doi.org\/10.1016\/J.UROLONC.2006.05.010","journal-title":"Urol Oncol"},{"issue":"1","key":"2384_CR8","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/J.EURURO.2013.12.018","volume":"66","author":"A Aziz","year":"2014","unstructured":"Aziz\u00a0A, May\u00a0M, Burger\u00a0M et\u00a0al (2014) Prediction of 90-day mortality after radical cystectomy for bladder cancer in a\u00a0prospective European multicenter cohort. Eur Urol 66(1):156\u2013163. https:\/\/doi.org\/10.1016\/J.EURURO.2013.12.018","journal-title":"Eur Urol"},{"issue":"6","key":"2384_CR9","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.21037\/TAU-20-713","volume":"9","author":"L Demaegd","year":"2020","unstructured":"Demaegd\u00a0L, Albersen\u00a0M, Muilwijk\u00a0T et\u00a0al (2020) Comparison of postoperative complications of ileal conduits versus orthotopic neobladders. Transl Androl Urol 9(6):2541\u20132554. https:\/\/doi.org\/10.21037\/TAU-20-713","journal-title":"Transl Androl Urol"},{"key":"2384_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/S11255-023-03897-3","author":"W Zhu","year":"2023","unstructured":"Zhu\u00a0W, Wu\u00a0L, Xie\u00a0W et\u00a0al (2023) Comparison of morbidity and mortality after radical cystectomy between individuals older and younger than 80\u00a0years: a\u00a0systematic review and meta-analysis. Int Urol Nephrol. https:\/\/doi.org\/10.1007\/S11255-023-03897-3","journal-title":"Int Urol Nephrol"},{"key":"2384_CR11","doi-asserted-by":"publisher","unstructured":"Kontis V, Bennett JE, Mathers CD, Li G, Foreman K, Ezzati M. Future life expectancy in 35 industrialised countries: projections with a\u00a0Bayesian model ensemble. Lancet (London, England). 2017;389(10076):1323\u20131335. https:\/\/doi.org\/10.1016\/S0140-6736(16)32381-9","DOI":"10.1016\/S0140-6736(16)32381-9"},{"key":"2384_CR12","doi-asserted-by":"publisher","unstructured":"Clark PE, Stein JP, Groshen SG, et\u00a0al. Radical cystectomy in the elderly: comparison of clincal outcomes between younger and older patients. Cancer. 2005;104(1):36\u201343. https:\/\/doi.org\/10.1002\/CNCR.21126","DOI":"10.1002\/CNCR.21126"},{"key":"2384_CR13","unstructured":"Deutsche Gesellschaft f\u00fcr Geriatrie DGG. https:\/\/www.dggeriatrie.de\/"},{"key":"2384_CR14","doi-asserted-by":"publisher","DOI":"10.1093\/GERONA\/56.3.M146","author":"LP Fried","year":"2001","unstructured":"Fried\u00a0LP, Tangen\u00a0CM, Walston\u00a0J et\u00a0al (2001) Frailty in older adults: evidence for a\u00a0phenotype. J\u00a0Gerontol A Biol Sci Med Sci. https:\/\/doi.org\/10.1093\/GERONA\/56.3.M146","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"8","key":"2384_CR15","doi-asserted-by":"publisher","first-page":"4690","DOI":"10.1245\/S10434-021-11321-2","volume":"29","author":"JF Shaw","year":"2022","unstructured":"Shaw\u00a0JF, Budiansky\u00a0D, Sharif\u00a0F, McIsaac\u00a0DI (2022) The Association of Frailty with Outcomes after Cancer Surgery: A\u00a0Systematic Review and Metaanalysis. ann Surg Oncol 29(8):4690\u20134704. https:\/\/doi.org\/10.1245\/S10434-021-11321-2","journal-title":"ann Surg Oncol"},{"key":"2384_CR16","doi-asserted-by":"publisher","unstructured":"Williams SB, Kamat AM, Chamie K, et\u00a0al. Systematic Review of Comorbidity and Competing-risks Assessments for Bladder Cancer Patients. Eur Urol Oncol. 2018;1(2):91\u2013100. https:\/\/doi.org\/10.1016\/J.EUO.2018.03.005","DOI":"10.1016\/J.EUO.2018.03.005"},{"issue":"3","key":"2384_CR17","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/J.EURURO.2009.05.008","volume":"56","author":"M Froehner","year":"2009","unstructured":"Froehner\u00a0M, Brausi\u00a0MA, Herr\u00a0HW, Muto\u00a0G, Studer\u00a0UE (2009) Complications following radical cystectomy for bladder cancer in the elderly. Eur Urol 56(3):443\u2013454. https:\/\/doi.org\/10.1016\/J.EURURO.2009.05.008","journal-title":"Eur Urol"},{"key":"2384_CR18","doi-asserted-by":"publisher","unstructured":"Wuethrich PY, Vidal A, Burkhard FC. There is a\u00a0place for radical cystectomy and urinary diversion, including orthotopic bladder substitution, in patients aged 75 and older: Results of a\u00a0retrospective observational analysis from a\u00a0high-volume center. Urol Oncol. 2016;34(2):58.e19\u201358.e27. https:\/\/doi.org\/10.1016\/J.UROLONC.2015.08.011","DOI":"10.1016\/J.UROLONC.2015.08.011"},{"issue":"5","key":"2384_CR19","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/J.UROLOGY.2007.11.125","volume":"71","author":"F Sogni","year":"2008","unstructured":"Sogni\u00a0F, Brausi\u00a0M, Frea\u00a0B et\u00a0al (2008) Morbidity and quality of life in elderly patients receiving ileal conduit or orthotopic neobladder after radical cystectomy for invasive bladder cancer. Urology 71(5):919\u2013923. https:\/\/doi.org\/10.1016\/J.UROLOGY.2007.11.125","journal-title":"Urology"},{"issue":"5","key":"2384_CR20","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/BJU.15274","volume":"127","author":"A Mortezavi","year":"2021","unstructured":"Mortezavi\u00a0A, Crippa\u00a0A, Edeling\u00a0S et\u00a0al (2021) Morbidity and mortality after robot-assisted radical cystectomy with intracorporeal urinary diversion in octogenarians: results from the European Association of Urology Robotic Urology Section Scientific Working Group. bju Int 127(5):585\u2013595. https:\/\/doi.org\/10.1111\/BJU.15274","journal-title":"bju Int"},{"issue":"6","key":"2384_CR21","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1016\/J.JURO.2010.02.015","volume":"183","author":"SM Donat","year":"2010","unstructured":"Donat\u00a0SM, Siegrist\u00a0T, Cronin\u00a0A, Savage\u00a0C, Milowsky\u00a0MI, Herr\u00a0HW (2010) Radical cystectomy in octogenarians\u2014does morbidity outweigh the potential survival benefits? j Urol 183(6):2171\u20132177. https:\/\/doi.org\/10.1016\/J.JURO.2010.02.015","journal-title":"j Urol"},{"key":"2384_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/S12877-020-01861-9","author":"S Huang","year":"2021","unstructured":"Huang\u00a0S, Chen\u00a0H, Li\u00a0T, Pu\u00a0X, Liu\u00a0J, Bi\u00a0X (2021) Comparison of survival in elderly patients treated with uretero-cutaneostomy or ileal conduit after radical cystectomy. bmc Geriatr. https:\/\/doi.org\/10.1186\/S12877-020-01861-9","journal-title":"bmc Geriatr"},{"issue":"1","key":"2384_CR23","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/S11255-006-9122-5","volume":"39","author":"K Yamanaka","year":"2007","unstructured":"Yamanaka\u00a0K, Miyake\u00a0H, Hara\u00a0I, Inoue\u00a0TA, Fujisawa\u00a0M (2007) Significance of radical cystectomy for bladder cancer in patients over 80\u00a0years old. Int Urol Nephrol 39(1):209\u2013214. https:\/\/doi.org\/10.1007\/S11255-006-9122-5","journal-title":"Int Urol Nephrol"},{"key":"2384_CR24","doi-asserted-by":"publisher","unstructured":"Parekh DJ, Gilbert WB, Koch MO, Smith JA. Continent urinary reconstruction versus ileal conduit: A\u00a0contemporary single-institution comparison of perioperative morbidity and mortality. Urology. 2000;55(6):852\u2013855. https:\/\/doi.org\/10.1016\/S0090-4295(99)00619-6","DOI":"10.1016\/S0090-4295(99)00619-6"},{"issue":"1","key":"2384_CR25","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1590\/S1677-5538.IBJU.2020.0892","volume":"48","author":"F Korkes","year":"2022","unstructured":"Korkes\u00a0F, Fernandes\u00a0E, Gushiken\u00a0FA et\u00a0al (2022) Bricker ileal conduit vs. Cutaneous ureterostomy after radical cystectomy for bladder cancer: a\u00a0systematic review. Int Braz J Urol 48(1):18\u201330. https:\/\/doi.org\/10.1590\/S1677-5538.IBJU.2020.0892","journal-title":"Int Braz J Urol"},{"issue":"2","key":"2384_CR26","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/J.UROLOGY.2005.03.031","volume":"66","author":"C Deliveliotis","year":"2005","unstructured":"Deliveliotis\u00a0C, Papatsoris\u00a0A, Chrisofos\u00a0M, Dellis\u00a0A, Liakouras\u00a0C, Skolarikos\u00a0A (2005) Urinary diversion in high-risk elderly patients: modified cutaneous ureterostomy or ileal conduit? Urology 66(2):299\u2013304. https:\/\/doi.org\/10.1016\/J.UROLOGY.2005.03.031","journal-title":"Urology"},{"key":"2384_CR27","doi-asserted-by":"crossref","unstructured":"Pycha A, Lodde M (2005) Uretero-Ureterocutaneostomy (Wrapped By Omentum). In: Hohenfellner R Fitzpatrick J Mcaninch J Eds advanced Urol Surg Third Ed","DOI":"10.1002\/9780470755914.ch53"},{"key":"2384_CR28","doi-asserted-by":"publisher","unstructured":"Kessler TM, Burkhard FC, Perimenis P, et\u00a0al. Attempted nerve sparing surgery and age have a\u00a0significant effect on urinary continence and erectile function after radical cystoprostatectomy and ileal orthotopic bladder substitution. J\u00a0Urol. 2004;172(4 Pt 1):1323\u20131327. https:\/\/doi.org\/10.1097\/01.JU.0000138249.31644.EC","DOI":"10.1097\/01.JU.0000138249.31644.EC"},{"issue":"3","key":"2384_CR29","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/J.SURONC.2016.05.027","volume":"25","author":"LS Yang","year":"2016","unstructured":"Yang\u00a0LS, Shan\u00a0BL, Shan\u00a0LL et\u00a0al (2016) A\u00a0systematic review and meta-analysis of quality of life outcomes after radical cystectomy for bladder cancer. Surg Oncol 25(3):281\u2013297. https:\/\/doi.org\/10.1016\/J.SURONC.2016.05.027","journal-title":"Surg Oncol"},{"key":"2384_CR30","doi-asserted-by":"publisher","DOI":"10.1007\/S00345-020-03385-8","author":"KD Clement","year":"2021","unstructured":"Clement\u00a0KD, Pearce\u00a0E, Gabr\u00a0AH, Rai\u00a0BP, Al-Ansari\u00a0A, Aboumarzouk\u00a0OM (2021) Perioperative outcomes and safety of robotic vs open cystectomy: a\u00a0systematic review and meta-analysis of 12,640 cases. World J Urol. https:\/\/doi.org\/10.1007\/S00345-020-03385-8","journal-title":"World J Urol"},{"issue":"20","key":"2384_CR31","doi-asserted-by":"publisher","first-page":"7590","DOI":"10.1002\/CAM4.3404","volume":"9","author":"X Su","year":"2020","unstructured":"Su\u00a0X, Wu\u00a0K, Wang\u00a0S et\u00a0al (2020) The impact of orthotopic neobladder vs ileal conduit urinary diversion after cystectomy on the survival outcomes in patients with bladder cancer: A\u00a0propensity score matched analysis. Cancer Med 9(20):7590\u20137600. https:\/\/doi.org\/10.1002\/CAM4.3404","journal-title":"Cancer Med"},{"issue":"1","key":"2384_CR32","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1097\/JU.0000000000000512","volume":"203","author":"DK Check","year":"2020","unstructured":"Check\u00a0DK, Leo\u00a0MC, Banegas\u00a0MP et\u00a0al (2020) Decision Regret Related to Urinary Diversion Choice among Patients Treated with Cystectomy. j Urol 203(1):159\u2013163. https:\/\/doi.org\/10.1097\/JU.0000000000000512","journal-title":"j Urol"},{"issue":"15","key":"2384_CR33","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1002\/CAM4.4667","volume":"11","author":"AK K\u00f6ther","year":"2022","unstructured":"K\u00f6ther\u00a0AK, B\u00fcdenbender\u00a0B, Gr\u00fcne\u00a0B et\u00a0al (2022) Different patients, different preferences: A\u00a0multicenter assessment of patients\u2019 personality traits and anxiety in shared decision making. Cancer Med 11(15):2999\u20133008. https:\/\/doi.org\/10.1002\/CAM4.4667","journal-title":"Cancer Med"},{"issue":"1","key":"2384_CR34","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/S00345-015-1706-1","volume":"34","author":"KM Siddiqui","year":"2016","unstructured":"Siddiqui\u00a0KM, Izawa\u00a0JI (2016) Ileal conduit: standard urinary diversion for elderly patients undergoing radical cystectomy. World J Urol 34(1):19\u201324. https:\/\/doi.org\/10.1007\/S00345-015-1706-1","journal-title":"World J Urol"},{"issue":"1","key":"2384_CR35","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/S00345-015-1696-Z","volume":"34","author":"CM Hugen","year":"2016","unstructured":"Hugen\u00a0CM, Daneshmand\u00a0S (2016) Orthotopic urinary diversion in the elderly. World J Urol 34(1):13\u201318. https:\/\/doi.org\/10.1007\/S00345-015-1696-Z","journal-title":"World J Urol"},{"issue":"4","key":"2384_CR36","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/BJU.13462","volume":"118","author":"N Longo","year":"2016","unstructured":"Longo\u00a0N, Imbimbo\u00a0C, Fusco\u00a0F et\u00a0al (2016) Complications and quality of life in elderly patients with several comorbidities undergoing cutaneous ureterostomy with single stoma or ileal conduit after radical cystectomy. bju Int 118(4):521\u2013526. https:\/\/doi.org\/10.1111\/BJU.13462","journal-title":"bju Int"},{"issue":"5","key":"2384_CR37","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1159\/000022097","volume":"45","author":"W M\u00fchlberg","year":"1999","unstructured":"M\u00fchlberg\u00a0W, Platt\u00a0D (1999) Age-dependent changes of the kidneys: pharmacological implications. Gerontology 45(5):243\u2013253. https:\/\/doi.org\/10.1159\/000022097","journal-title":"Gerontology."},{"issue":"1","key":"2384_CR38","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/BJU.12121","volume":"113","author":"RK Lee","year":"2014","unstructured":"Lee\u00a0RK, Abol-Enein\u00a0H, Artibani\u00a0W et\u00a0al (2014) Urinary diversion after radical cystectomy for bladder cancer: options, patient selection, and outcomes. bju Int 113(1):11\u201323. https:\/\/doi.org\/10.1111\/BJU.12121","journal-title":"bju Int"},{"key":"2384_CR39","doi-asserted-by":"publisher","first-page":"333","DOI":"10.2147\/RRU.S181473","volume":"11","author":"QLGN Lawrentschuk","year":"2019","unstructured":"Lawrentschuk\u00a0QLGN (2019) Orthotopic Neobladder Reconstruction: Patient Selection And Perspectives. Res reports. Urol 11:333\u2013341. https:\/\/doi.org\/10.2147\/RRU.S181473","journal-title":"Urol"},{"key":"2384_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/J.JGO.2023.101468","author":"S Yajima","year":"2023","unstructured":"Yajima\u00a0S, Nakanishi\u00a0Y, Yasujima\u00a0R et\u00a0al (2023) Rapid geriatric screening tools predict inability to manage stoma by oneself after urinary diversion: G8 and IADL-modified G8. J\u00a0Geriatr Oncol. https:\/\/doi.org\/10.1016\/J.JGO.2023.101468","journal-title":"J Geriatr Oncol"}],"container-title":["Die Urologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-024-02384-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00120-024-02384-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-024-02384-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T21:12:24Z","timestamp":1722028344000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00120-024-02384-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,16]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["2384"],"URL":"https:\/\/doi.org\/10.1007\/s00120-024-02384-6","relation":{},"ISSN":["2731-7064","2731-7072"],"issn-type":[{"type":"print","value":"2731-7064"},{"type":"electronic","value":"2731-7072"}],"subject":[],"published":{"date-parts":[[2024,7,16]]},"assertion":[{"value":"5 June 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"<b>D.\u00a0Oswald<\/b>: A.\u00a0Finanzielle Interessen: D.\u00a0Oswald gibt an, dass kein finanzieller Interessenkonflikt besteht. \u2013\u00a0B.\u00a0Nichtfinanzielle Interessen: Facharzt f\u00fcr Urologie, Universit\u00e4tsklinikum Salzburg | Mitgliedschaften: \u00d6sterreichische Gesellschaft f\u00fcr Urologie und Andrologie (\u00d6GU), Online-Mitglied European Association of Urology (EAU).<b> T.R.W.\u00a0Herrmann<\/b>: A.\u00a0Finanzielle Interessen: Forschungsf\u00f6rderung zur pers\u00f6nlichen Verf\u00fcgung: Company Consultant Karl Storz.\u00a0\u2013 Vortragshonorare oder Kostenerstattung als passiv Teilnehmende: Coloplast, Jansen, Karl Storz. \u2013\u00a0bezahlte Beratungsleistungen, interne Schulungsvortr\u00e4ge, Gehaltsbezug o.\u202f\u00c4.: Karl Storz, Consulting, Referent.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Klinikdirektor Urologie, Spital Thurgau AG (STGAG), CH; Chefarzt Urologie, Kantonsspital Frauenfeld, CH | Arbeitskreis (AK) Endourologie der Deutschen Gesellschaft f\u00fcr Urologie (DGU); AK Operative Techniken, DGU; Editor in Chief <i>World Journal of Urology<\/i>; erweiterter Vorstand Schweizerische Gesellschaft f\u00fcr Urologie (SGU); EAU Guidelines Male LUTS.<b> C.\u00a0Netsch<\/b>: A.\u00a0Finanzielle Interessen: Richard Wolf: Proctor, Berater, Vortragst\u00e4tigkeit. \u2013\u00a0B.\u00a0Nichtfinanzielle Interessen: Oberarzt, AK Barmbek, Abteilung f\u00fcr Urologie | Mitgliedschaften: DGU, Endourological Society, EAU, EAU Section of Uro<i>-<\/i>Technology (ESUT), AK Endourologie, Vereinigung Norddeutscher Urologen (VNU), Kontinenzgesellschaft, Focal Therapy Society, Vorsitzender AK Endourologie.<b> B.\u00a0Becker<\/b>: A.\u00a0Finanzielle Interessen: bezahlte Beratungsleistungen, interne Schulungsvortr\u00e4ge, Gehaltsbezug o.\u202f\u00c4.: Richard Wolf: Berater, Vortragst\u00e4tigkeit.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Oberarzt, AK Barmbek, Abteilung f\u00fcr Urologie | Mitgliedschaften: DGU, Endourological Society, AK Endourologie, VNU.<b> G.\u00a0Hatiboglu<\/b>: A.\u00a0Finanzielle Interessen: G.\u00a0Hatiboglu gibt an, dass kein finanzieller Interessenkonflikt besteht. \u2013\u00a0B.\u00a0Nichtfinanzielle Interessen: Klinikdirektor Urologie, SLK Klinken, Heilbronn | Mitgliedschaften: DGU, Deutsche Gesellschaft f\u00fcr Roboter-assistierte Urologie (DGRU), EAU, AK Endourologie.<b> R.\u00a0Homberg<\/b>: A.\u00a0Finanzielle Interessen: bezahlte Beratungsleistungen, interne Schulungsvortr\u00e4ge, Gehaltsbezug o.\u202f\u00c4.: Boston Scientific\u00a0\u2013 Proctorship, Olympus \u2013\u00a0Organisation von Workshops.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Chefarzt, Klinik f\u00fcr Urologie, Hamm | Mitgliedschaften: DGU, AK Endourologie, EAU.<b> J.T.\u00a0Klein<\/b>: A.\u00a0Finanzielle Interessen: J.-T.\u00a0Klein gibt an, dass kein finanzieller Interessenkonflikt besteht. \u2013\u00a0B.\u00a0Nichtfinanzielle Interessen: Chefarzt, Urologische Klinik M\u00fcnsterlingen, STGAG, Schweiz, seit 13\u00a0Monaten; Chefarzt, Urologische Klinik am Lerchenberg, Heilbronn, 2020\u20132023; niedergelassener Urologe, Urologische Praxis am Lerchenberg GmbH, Heilbronn; Konsiliararzt, Urologische Abteilung, Uniklinik Ulm, seit 2020; angestellter leitender Oberarzt, Urologie, Uniklinik Ulm, Ulm, 2015\u20132020.<b> K.\u00a0Lehrich<\/b>: A.\u00a0Finanzielle Interessen: Vortragshonorare oder Kostenerstattung als passiv Teilnehmende: Boston Scientific. \u2013\u00a0Boston Scientific: Proctor, Pr\u00e4sentationen, Coloplast: Beratung, Pr\u00e4sentationen.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Ober\u00e4rztin, Klinik f\u00fcr Urologie, und Leiterin des Urologischen Laserzentrums am Vivantes Auguste-Viktoria-Klinikum, Berlin.<b> A.\u00a0Miernik<\/b>: A.\u00a0Finanzielle Interessen: A.\u00a0Miernik gibt an, dass kein finanzieller Interessenkonflikt besteht. \u2013\u00a0B.\u00a0Nichtfinanzielle Interessen: Sektionsleiter Urotechnologie, gesch\u00e4ftsf\u00fchrender Oberarzt, Personaloberarzt, Universit\u00e4tsklinikum Freiburg\u00a0| Mitgliedschaften: DGU, EAU, Endourological Society, American Urological Association (AUA), Deutsche Gesellschaft f\u00fcr Extrakorporale Sto\u00dfwellentherapie (DIGEST).<b> P.\u00a0Olbert<\/b>: A.\u00a0Finanzielle Interessen: P.\u00a0Olbert gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: niedergelassener Urologe, Freiberufler | Mitgliedschaften: DGU, EAU, American Society of Clinical Oncology (ASCO).<b> D.S.\u00a0Sch\u00f6b<\/b>: A.\u00a0Finanzielle Interessen: D.\u00a0Schoeb gibt an, dass kein finanzieller Interessenkonflikt besteht. \u2013\u00a0B.\u00a0Nichtfinanzielle Interessen: Facharzt, Uniklinik Freiburg; Facharzt, Urologie, M\u00fcllheim | Mitgliedschaften: DGU, AK Endourologie.<b> K.D.\u00a0Sievert<\/b>: A.\u00a0Finanzielle Interessen: K.-D.\u00a0Sievert gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Direktor, Klinikum Lippe, Universit\u00e4tsklinik f\u00fcr Urologie, Universit\u00e4t Bielefeld, Medizinische Fakult\u00e4t, UK-OWL, Campus Klinikum Lippe, Klinkum Lippe | Mitgliedschaften: EAU, EAU Section of Functional Urology (ESFU), EAU Section of Genitourinary Reconstructive Surgeons (ESGURS), DGU und Mitglied des AK Endourologie, AUA, DKG.<b> J.\u00a0Herrmann<\/b>: A.\u00a0Finanzielle Interessen: Vortragshonorar: Boston Scientific. \u2013\u00a0Bezahlte Beratungsleistungen, interne Schulungsvortr\u00e4ge, Gehaltsbezug o.\u202f\u00c4.: Boston Scientific, Proctor f\u00fcr HoLEP-Operationen.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: angestellter Arzt, Uniklinikum Mannheim, ab 01.06.2024 am Auguste-Viktoria-Klinikum Berlin | Mitglied des AK Endourologie der DGU.<b> A.J.\u00a0Gross<\/b>: A.\u00a0Finanzielle Interessen: A.\u00a0J. Gross gibt an, dass kein finanzieller Interessenkonflikt besteht. \u2013\u00a0B.\u00a0Nichtfinanzielle Interessen: Chefarzt, Abteilung f\u00fcr Urologie, Asklepios Klinik Barmbek, Hamburg | Endourological Society: President-elect.<b> M.\u00a0Pallauf<\/b>: A.\u00a0Finanzielle Interessen: Forschungsf\u00f6rderung zur pers\u00f6nlichen Verf\u00fcgung: 2021 \u2013\u00a0\u00d6GU, \u00dcbelh\u00f6r (Stipendium)\u00a0| 2023\u00a0\u2013 Paracelsus Medizinische Privatuniversit\u00e4t, FIRE (Stipendium). \u2013\u00a0Vortragshonorare oder Kostenerstattung als passiv Teilnehmende: 2019\u00a0\u2013 Baxter\u00a0| 2019 \u2013\u00a0Pfizer\u00a0| 2021\u00a0\u2013 Ipsen\u00a0| 2024 \u2013\u00a0Janssen.\u00a0\u2013 bezahlte Beratungsleistungen, interne Schulungsvortr\u00e4ge, Gehaltsbezug o.\u202f\u00c4.: 2019\/2021 \u2013\u00a0Astellas\u00a0| 2022\u00a0\u2013 Janssen\u00a0| 2023 \u2013\u00a0AstraZeneca\u00a0| 2023\u00a0\u2013 BMS. \u2013\u00a0B.\u00a0Nichtfinanzielle Interessen: Facharzt f\u00fcr Urologie, Universit\u00e4tsklinik f\u00fcr Urologie, Salzburg, \u00d6sterreich | Managing Editor <i>World Journal of Urology<\/i>.<b> S.\u00a0Deininger<\/b>: A.\u00a0Finanzielle Interessen: Vortragshonorar: Merck.\u00a0\u2013 bezahlte Beratungsleistungen, interne Schulungsvortr\u00e4ge, Gehaltsbezug o.\u202f\u00c4.: Vortragshonorar: Merck. \u2013\u00a0B.\u00a0Nichtfinanzielle Interessen: angestellte \u00c4rztin, Universit\u00e4tsklinik f\u00fcr Urologie und Andrologie, Paracelsus Medizinische Universit\u00e4t, Salzburg, \u00d6sterreich | Mitgliedschaften: EAU, \u00d6GU.<b> C.\u00a0Ramesmayer<\/b>: A.\u00a0Finanzielle Interessen: C.\u00a0Ramesmayer gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Angestellter, Universit\u00e4tsklinik f\u00fcr Urologie und Andrologie, SALK Salzburg.<b> J.\u00a0Peters<\/b>: A.\u00a0Finanzielle Interessen: J.\u00a0K. Peters gibt an, dass kein finanzieller Interessenkonflikt besteht. \u2013\u00a0B.\u00a0Nichtfinanzielle Interessen: Ausbildungs\u00e4rztin zur Fach\u00e4rztin, Universit\u00e4tsklinik f\u00fcr Urologie und Andrologie, Salzburg. <b>L.\u00a0Lusuardi<\/b>: A.\u00a0Finanzielle Interessen: L.\u00a0Lusuardi gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Vorstand der Urologie, Paracelsus Medizinische Universit\u00e4t, Salzburg, \u00d6sterreich | stellvertretender Leiter AK Endourologie der DGU.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}